Article (Scientific journals)
Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning
Baron, Frédéric; Sandmaier, Brenda M.; Storer, Barry E. et al.
2007In Biology of Blood and Marrow Transplantation, 13 (9), p. 1041-1048
Peer Reviewed verified by ORBi
 

Files


Full Text
Articl1668BBMT04.pdf
Publisher postprint (237.79 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
unrelated hematopoietic cell transplantation; mycophenolate mofetil; cyclosporine; graft-versus-host disease
Abstract :
[en] We previously reported data from 103 patients with hematologic malignancies (median age 54 years) who received peripheral blood stem cell (PBSC) grafts from HLA-matched unrelated donors after nonmycloablative conditioning and were given postgrafting immunosuppression consisting of mycophenolate mofetil (MMF; administered from day 0 until day + 40 with taper through day + 96) and cyclosporine (CSP; given from day -3 to day + 100, with taper through day 180) (historical patients). The incidences of grade II-IV acute and extensive chronic graft-versus-host disease (aGVHD, cGVHD) were 52% and 49%, respectively, and the 1-year probabilities of relapse, nonrelapse mortality (NRM), and progression-free survival (PFS) were 26%, 18%, and 56%, respectively. Here, we treated 71 patients with hematologic malignancies (median age 56 years) with unrelated PBSC grafts and investigated whether postgrafting immunosuppression with an extended course of NMF, given at full dosing until day + 150 and then tapered through day + 180, and a shortened course of CSP, through day + 80, would promote tolerance induction and reduce the incidence of GVHD (current patients). We observed 77% grade ll-1V aGVHD and 45% extensive cGVHD (P =.03, and P =.43, respectively, in current compared to historical patients). The 1-year probabilities of relapse, NRM, and PFS were 23%, 29%, and 47%, respectively (P =.89, P =.02, and P =.08 compared to the historical patients). We conclude that postgrafting immunosuppression with extended MMF and shortened CSP failed to decrease the incidence of GVHD among unrelated PBSC recipients given nonmyeloablative conditioning. (c) 2007 American Society for Blood and Marrow Transplantation
Disciplines :
Surgery
Immunology & infectious disease
Hematology
Author, co-author :
Baron, Frédéric  ;  Université de Liège - ULiège > Département des sciences cliniques > Hématologie
Sandmaier, Brenda M.
Storer, Barry E.
Maris, Michaël B.
Langston, Amelia A.
Lange, Thoralf
Petersdorf, Effie
Bethge, Wolfgang
Maziarz, Richard T.
McSweeney, Peter A.
Pulsipher, Michael A.
Wade, James C.
Chauncey, Thomas R.
Sbizuru, Judith A.
Sorror, Mohamed L.
Woolfrey, Ann E.
Maloney, David G.
Storb, Rainer
More authors (8 more) Less
Language :
English
Title :
Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning
Publication date :
September 2007
Journal title :
Biology of Blood and Marrow Transplantation
ISSN :
1083-8791
eISSN :
1523-6536
Publisher :
Elsevier Science Inc, New York, United States - New York
Volume :
13
Issue :
9
Pages :
1041-1048
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 18 September 2009

Statistics


Number of views
141 (0 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
23
Scopus citations®
without self-citations
5
OpenCitations
 
18

Bibliography


Similar publications



Contact ORBi